Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Evaluation of poliovirus antibody titers in orally vaccinated semi‐captive chimpanzees in Uganda

View through CrossRef
AbstractBackground  To understand immunological responses in chimpanzees vaccinated with live‐attenuated vaccine (oral polio vaccine; OPV), serum neutralizing antibodies against poliovirus types 1, 2, and 3 were investigated over time.Methods  The neutralizing antibody titers against poliovirus types 1, 2, and 3 were determined by microneutralization test using 100 ID50 of poliovirus types 1, 2, and 3 (Sabin strains).Results  Neutralizing antibodies against poliovirus types 1, 2, and 3 were detected in 85.7%, 71.4%, and 65% of the serum from 42 chimpanzees tested 9 years post‐vaccination. The neutralizing antibody titers in chimpanzees were similar to the documented levels in human studies as an indicator of vaccine efficacy.Conclusions  This study reveals persistence of neutralizing antibodies in chimpanzees for at least 9 years after vaccination with OPV. This first study in chimpanzees provides useful information for the evaluation of the success of vaccination with OPV in other captive apes.
Title: Evaluation of poliovirus antibody titers in orally vaccinated semi‐captive chimpanzees in Uganda
Description:
AbstractBackground  To understand immunological responses in chimpanzees vaccinated with live‐attenuated vaccine (oral polio vaccine; OPV), serum neutralizing antibodies against poliovirus types 1, 2, and 3 were investigated over time.
Methods  The neutralizing antibody titers against poliovirus types 1, 2, and 3 were determined by microneutralization test using 100 ID50 of poliovirus types 1, 2, and 3 (Sabin strains).
Results  Neutralizing antibodies against poliovirus types 1, 2, and 3 were detected in 85.
7%, 71.
4%, and 65% of the serum from 42 chimpanzees tested 9 years post‐vaccination.
The neutralizing antibody titers in chimpanzees were similar to the documented levels in human studies as an indicator of vaccine efficacy.
Conclusions  This study reveals persistence of neutralizing antibodies in chimpanzees for at least 9 years after vaccination with OPV.
This first study in chimpanzees provides useful information for the evaluation of the success of vaccination with OPV in other captive apes.

Related Results

Covid-19: Relative risks of non-vaccinated to vaccinated individuals
Covid-19: Relative risks of non-vaccinated to vaccinated individuals
Abstract ObjectivesThe aim of this study was to evaluate and quantify the relative risk of hospital admission and death because of Sars-Cov2 infection between non-vaccinate...
Electrocardiogram reference intervals for clinically normal wild-born chimpanzees (Pan troglodytes)
Electrocardiogram reference intervals for clinically normal wild-born chimpanzees (Pan troglodytes)
Abstract OBJECTIVE To generate reference intervals for ECG variables in clinically normal chimpanzees (Pan troglodytes). ANIMALS 100 clinically normal (51 young [< 10 years old]...
Features of humoral immunity in cows infected with the leukaemia virus
Features of humoral immunity in cows infected with the leukaemia virus
The article presents the results of studying the dynamics of the formation of antibodies and immune complexes, reveals the prospects for improving the early diagnosis of cattle leu...
Sex differences in pant-hoot vocalizations in wild Eastern chimpanzees
Sex differences in pant-hoot vocalizations in wild Eastern chimpanzees
Abstract Chimpanzee pant-hoots are frequently produced long-distance vocalisations that serve a number of social functions, such as to indicate c...
Procedure for Western blot v1
Procedure for Western blot v1
Goal: This document has the objective of standardizing the protocol for Western blot. This technique allows the detection of specific proteins separated on polyacrylamide gel and t...

Back to Top